Monday, May 15, 2017 3:10:00 PM
I believe the early technology going back ten years was legacy technology and subsequently found to be valueless, and the two later technologies invented by the CEO were a major change of direction for the company which will enrich all of us who are shareholders.
The petri flat packaging should have good appeal to markets worldwide, and the N-Assay should also have very broad appeal around the world.
As for a ten year period being cited as indicative of lack of management capabilities, I must opine that for them to have spent much time on development of the legacy technologies would have meant that any of you who were invested from 2007 and through the subsequent years until the undoubted end of Nanologix would have meant that you would have lost everything and I and others who came later would have never invested because there wouldn't have been a company to invest in.
So I view management as far from lacking.
Most of this comes from information I have gleaned through due diligence and in my quest to update this website.
EI
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM